Patent details

Basic Information

Publication number:

EP2568971

PCT Application Number:

JP2011061354

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117258251

PCT Publication Number:

WO2011142478

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CANAGLIFLOZIN CONTAINING TABLETS

French Title of Invention:

COMPRIMÉS CONTENANT DE LA CANAGLIFLOZINE

German Title of Invention:

TABLETTEN ENTHALTEND CANAGLIFLOZIN

SPC Number:

Dates

Filing date:

11/05/2011

Grant date:

14/10/2020

EP Publication Date:

20/03/2013

PCT Publication Date:

17/11/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/10/2020

EP B1 Publication Date:

14/10/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/05/2021

Expiration date:

11/05/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/10/2020

 

 

Name:

Mitsubishi Tanabe Pharma Corporation

Address:

3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505, Japan (JP)

Inventor

1

Name:

TOKUDA Takayuki

Address:

Japan (JP)

2

Name:

KINOSHITA Hajime

Address:

Japan (JP)

3

Name:

SUGIMOTO Masaaki

Address:

Japan (JP)

Priority

Priority Number:

333312 P

Priority Date:

11/05/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/20; A61K 9/28; A61K 31/381; A61K 31/7034; A61K 31/7042; A61P 3/04; A61P 3/06; A61P 3/08; A61P 3/10; A61P 9/10; A61P 9/12; A61P 13/12; A61P 17/02; A61P 25/00; A61P 27/02;

Publication

European Patent Bulletin

Issue number:

202042

Publication date:

14/10/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages